HIGHLIGHTS
- who: from the (UNIVERSITY) have published the paper: CORRIGENDUM DOI: 10.3892/or.2022.8411 TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma, in the Journal: (JOURNAL)
SUMMARY
ONCOLOGY REPORTS 48: 196, 2022 CORRIGENDUM @@
ACRONYMS
LAY DEFINITIONS
Licence: cc-by
Site reference: https://www.spandidos-publications.com/10.3892/or.2022.8411/download
DOI reference:
If you want to have access to all the content you need to log in! Thanks :)
If you don't have an account, you can create one here. 